|
1
|
Camlio A, Cecilia SP, Valeria H and Marcos
S: Analysis of the relationship between the referral and evolution
of patients with type 2 diabetes mellitus. Int J Environ Res Public
Health. 15:15342018. View Article : Google Scholar
|
|
2
|
Mashitisho ML and Mashitisho BG: Early
insulin therapy in patients with type 2 diabetes mellitus. J
Endocrinol Metab Diab South Africa. 21:13–15. 2016. View Article : Google Scholar
|
|
3
|
Gu J, Wei Q, Zheng H, Meng X, Zhang J and
Wang D: Exendin-4 promotes survival of mouse pancreatic β-cell line
in lipotoxic conditions, through the extracellular signal-related
kinase 1/2 pathway. J Diabetes Res. 2016:52940252016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Good DJ, Polverini PJ, Rastinejad F, Le
Beau MM, Lemons RS, Frazier WA and Bouck NP: A tumor
suppressor-dependent inhibitor of angiogenesis is immunologically
and functionally indistinguishable from a fragment of
thrombospondin. Proc Natl Acad Sci USA. 87:6624–6628. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adams JC and Lawler J: The
thrombospondins. Int J Biochem Cell Biol. 36:961–968. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Savill J, Fadok V, Henson P and Haslett C:
Phagocyte recognition of cells undergoing apoptosis. Immunol Today.
14:131–136. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ribeiro SM, Poczatek M, Schultz-Cherry S,
Villain M and Murphy-Ullrich JE: The activation sequence of
thrombospondin-1 interacts with the latency-associated peptide to
regulate activation of latent transforming growth factor-beta. J
Biol Chem. 274:13586–13593. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Matsuo Y, Tanska M, Yamakage H, Sasaki Y,
Muranaka K, Hata H, Ikai I, Shimatsu A, Inoue M, Chun TH and
Satoh-Asahara N: Thrombospondin 1 as a novel biological marker of
obesity and metabolic syndrome. Metabolism. 64:1490–1499. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Delić D, Eisele C, Schmid R, Baum P, Wiech
F, Gerl M, Zimdahl H, Pullen SS and Urquhart R: Urinary exosomal
miRNA signature in type II diabetic nephropathy patients. PLoS One.
11:e01501542016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olerud J, Mokhtari D, Johansson M,
Christoffersson G, Lawler J, Welsh N and Carlsson PO:
Thrombospondin-1: An islet endothelial cell signal of importance
for β-cell function. Diabetes. 60:1946–1954. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu X, Li Y, Alvero A, Li J, Wu Q, Xiao Q,
Peng Y, Hu Y, Li X, Yan W, et al: MicroRNA-222-3p/GNAI2/AKT axis
inhibits epithelial ovarian cancer cell growth and associates with
good overall survival. Oncotarget. 7:80633–80654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Y, Zhang T, Zhou Y, Sun Y, Cao Y, Chang
X, Zhu Y and Han X: A presenilin/Notch1 pathway regulated by
miR-375, miR-30a, and miR-34a mediates glucotoxicity
induced-pancreatic beta cell apoptosis. Sci Rep. 6:361362016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Shi C, Wang C, Liu W, Chu Y, Xiang
Z, Hu K, Dong P and Han X: The role of miR-497-5p in myofibroblast
differentiation of LR-MSCs and pulmonary fibrogenesis. Sci Rep.
7:409582017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin X, Guan H, Huang Z, Liu J, Li H, Wei
G, Cao X and Li Y: Downregulation of Bcl-2 expression by miR-34a
mediates palmitate-induced Min6 cells apoptosis. J Diabetes Res.
2014:2586952014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Y, Xu X, Liang Y, Liu S, Xiao H, Li F,
Cheng H and Fu Z: miR-375 enhances palmitate-induced lipoapoptosis
in insulin-secreting NIT-1 cells by repression myotrophin (V1)
protein expression. Int J Clin Exp Pathol. 3:254–264.
2010.PubMed/NCBI
|
|
16
|
Lovis P, Roggli E, Laybutt DR, Gattesco S,
Yang JY, Widmann C, Abderrahmani A and Regazzi R: Alterations in
microRNA expression contribute to fatty acid-induced pancreatic
beta-cell dysfunction. Diabetes. 57:2728–2736. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yao J, Xu C, Fang Z, Li Y, Liu H, Wang Y,
Xu C and Sun Y: Androgen receptor regulated microRNA miR-182-5p
promotes prostate cancer progression by targeting the ARRDC3/ITGB4
pathway. Biochem Biophys Res Commun. 474:213–219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jiang W, Liu G and Tang W: MicroRNA-182-5p
ameliorates liver ischemia-reperfusion injury by suppressing
Toll-like receptor 4. Transplant Proc. 48:2809–2814. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blume CJ, Hotz-Wagenblatt A, Hüllein J,
Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A,
Benner A, et al: p53-dependent non-coding RNA networks in chronic
lymphocytic leukemia. Leukemia. 29:2015–2023. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
International Diabetes Federation. IDF
diabetes atlas. 7:(Brussels). International Diabetes Federation.
2015.
|
|
22
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 36((Suppl
1)): S67–S74. 2013.PubMed/NCBI
|
|
23
|
American Diabetes Association: Diagnosis
and classification of diabetes mellitus. Diabetes Care. 37((Suppl
1)): S81–S90. 2014.PubMed/NCBI
|
|
24
|
Prentki M and Nolan CJ: Islet beta cell
failure in type 2 diabetes. J Clin Invest. 116:1802–1812. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hull RL, Kodama K, Utzschneider KM, Carr
DB, Prigeon RL and Kahn SE: Dietary-fat-induced obesity in mice
results in beta cell hyperplasia but not increased insulin release:
Evidence for specificity of impaired beta cell adaptation.
Diabetologia. 48:1350–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Poitout V, Amyot J, Semache M, Zarrouki B,
Hagman D and Fontés G: Glucolipotoxicity of the pancreatic beta
cell. Biochim Biophys Acta. 1801:289–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Inoue M, Jiang Y, Barnes RH II, Tokunaga
M, Martinez-Santibañez G, Geletka L, Lumeng CN, Buchner DA and Chun
TH: Thrombospondin 1 mediates high-fat diet-induced muscle fibrosis
and insulin resistance in male mice. Endocrinology. 154:4548–4559.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kong P, Gonzalez-Quesada C, Li N, Cavalera
M, Lee DW and Frangogiannis NG: Thrombospondin-1 regulates
adiposity and metabolic dysfunction in diet-induced obesity
enhancing adipose inflammation and stimulating adipocyte
proliferation. Am J Physiol Endocrinol Metab. 305:E439–E450. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Terracciano D, Terreri S, de Nigris F,
Costa V, Celin GA and Cimmino A: The role of a new class of long
noncoding RNAs transcribed from ultraconserved regions in cancer.
Biochim Biophys Acta Rev Cancer. 1868:449–495. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yin J, Ren W, Huang X, Li T and Yin Y:
Protein restriction and cancer. Biochim Biophys Acta Rev Cancer.
1869:256–262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhi F, Shao N, Xue L, Xu Y, Kang X, Yang Y
and Xia Y: Characteristic microRNA expression induced by δ-opioid
receptor activation in the rat liver under prolonged hypoxia. Cell
Physiol Biochem. 44:2296–2309. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cazanave SC, Mott JL, Elmi NA, Bronk SF,
Masuoka HC, Charlton MR and Gores GJ: A role for miR-296 in the
regulation of lipoapoptosis by targeting PUMA. J Lipid Res.
52:1517–1525. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han YB, Wang MN, Li Q, Guo L, Yang YM, Li
PJ, Wang W and Zhang JC: MicroRNA-34a contributes to the protective
effects of glucagon-like peptide-1 against lipotoxicity in INS-1
cell. Chin Med J (Engl). 125:4202–4208. 2012.PubMed/NCBI
|
